Black Diamond Therapeutics, Inc. Common Stock BDTX
$2.03
+2.53%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-42,555,000
- Net Margin
- —
- Return on Equity
- -44.29%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 1.18
- Price / Sales
- —
Over the trailing twelve months, Black Diamond Therapeutics, Inc. Common Stock generated revenue of — and net income of $-42,555,000.
Key Stats
- Last Close
- $2.03
- Market Cap
- $113.76 million
- 52-Week Range
- $1.60 – $4.94
- Average Volume
- 569K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.